To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
InCarda Therapeutics lands $30m
Newark, California-based InCarda Therapeutics Inc, a developer of inhaled therapies for cardiovascular diseases, has raised $30 million in financing.
